HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Gustavo E Velásquez Selected Research
Gustavo E Velásquez Research Topics
Disease
8
Tuberculosis (Tuberculoses)
04/2024 - 07/2014
3
Pulmonary Tuberculosis
04/2024 - 01/2018
3
COVID-19
02/2023 - 01/2022
3
Infections
10/2020 - 01/2016
3
Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
03/2017 - 07/2014
1
Exanthema (Rash)
04/2024
1
Vomiting
04/2024
1
Nausea
10/2020
1
Bacterial Pneumonia
10/2020
1
Mycoses (Diseases, Fungus)
01/2018
1
Rheumatoid Arthritis
01/2018
1
Histoplasmosis
01/2018
1
Ebola Hemorrhagic Fever
01/2016
Drug/Important Bio-Agent (IBA)
4
Rifampin (Rifampicin)
FDA Link
Generic
03/2024 - 07/2014
3
Pyrazinamide
FDA Link
Generic
04/2024 - 11/2016
3
Isoniazid (Ftivazide)
FDA Link
Generic
04/2024 - 07/2014
1
Transaminases (Aminotransferases)
IBA
04/2024
1
Moxifloxacin (Avelox)
FDA Link
04/2024
1
rifapentine (Priftin)
FDA Link
04/2024
1
Immunoglobulin G (IgG)
IBA
02/2023
1
Immunoglobulin M (IgM)
IBA
02/2023
1
Rifamycins
IBA
01/2023
1
pretomanid
IBA
01/2023
1
COVID-19 Vaccines
IBA
09/2022
1
Antigens
IBA
01/2022
1
omadacycline
IBA
10/2020
1
Drug Combinations
IBA
01/2019
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2018
1
Abatacept (Orencia)
FDA Link
01/2018
1
Vaccines
IBA
01/2016
1
Fluoroquinolones
IBA
07/2014
Therapy/Procedure
4
Therapeutics
10/2020 - 07/2014